Benefits of plerixafor for mobilization of peripheral blood stem cells prior to autologous transplantation: a dual-center retrospective cohort study.

Naokazu Nakamura,Tomoyasu Jo,Yasuyuki Arai,Mayumi Matsumoto,Tomomi Sakai,Hiroko Tsunemine,Akifumi Takaori-Kondo,Nobuyoshi Arima

Cytotherapy（2023）

引用 0|浏览10

暂无评分

摘要

The authors conclude that plerixafor may be safe to use and that it reduces the risk of infection in patients with a low CD34+ cell count the day before apheresis.

查看译文

关键词

autologous stem cell transplantation,engraftment,mobilization,plerixafor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要